Why Semaglutide Can Cause Yeast Infections — and What to Do About It

You started semaglutide, you got thrush, and now you're wondering if one caused the other

That is a completely reasonable thing to wonder. The timing is suspicious enough to feel meaningful, and yet most information about semaglutide's side effects focuses on nausea and gut symptoms, leaving the yeast-infection question poorly answered.

Here is the honest picture. Semaglutide, the active medicine in Wegovy, reduces appetite and slows gastric emptying. It also lowers blood glucose, which is part of why it was first developed for type 2 diabetes. In most people taking it for weight management, blood sugar gradually comes down over weeks. But the transition matters. In the period before glucose is well controlled, higher-than-optimal levels of sugar in the body provide fuel for Candida albicans, the yeast responsible for most thrush and vaginal yeast infections. The NHS medicines guidance on semaglutide notes genital fungal infections among side effects reported in trials, particularly in patients with diabetes or impaired glucose regulation. If your glucose was running high before you started treatment, that window of change can briefly tip conditions in the yeast's favour.

It is also worth knowing that semaglutide itself is not antifungal or pro-fungal in any direct pharmacological sense. The effect is entirely downstream of glucose metabolism. That distinction matters because it shapes what you should do about it, and what to realistically expect going forward.

Why some people are more likely to notice this than others

Not everyone on semaglutide develops a yeast infection. The risk is meaningfully higher in people who already had elevated blood sugar, prediabetes, or type 2 diabetes before starting treatment. It is also higher in people who have a history of recurrent thrush regardless of medication. Warm, moist conditions, certain antibiotics taken concurrently, and hormonal factors all stack on top of the glucose picture.

For people with no glucose regulation issues, the connection to semaglutide is much weaker. In the STEP 1 trial published in the New England Journal of Medicine, participants were adults with obesity but without diabetes. The rate of genital yeast infections in that population was low, broadly consistent with background rates, which supports the view that blood sugar dysregulation is the key mediating factor rather than semaglutide itself acting on fungal populations directly.

If you have also noticed changes in digestion since starting treatment, that is a separate and common adjustment. The gastrointestinal effects of semaglutide have a different mechanism again, driven by slowed gastric motility rather than glucose changes, and they tend to settle faster.

What you can actually do about it

A single yeast infection that responds to standard over-the-counter antifungal treatment (topical or oral, depending on what you normally use and your GP's advice) does not in itself require you to stop semaglutide or change your dose. Manage it as you would any other episode of thrush.

Recurrent infections, or infections that are unusually severe or slow to resolve, are worth raising with a prescriber. They may indicate that your blood glucose is taking longer to stabilise than expected, or that another factor needs investigation. The NHS medicines page for semaglutide is a reliable reference for the full side-effect profile and when to seek medical advice.

There are also practical steps that reduce risk without touching your treatment: keeping the affected area dry, wearing breathable cotton underwear, avoiding scented soaps in the area, and staying well hydrated. None of this is specific to semaglutide, but it matters more when glucose is in flux.

For context on how semaglutide produces weight loss in the first place, and what the broader metabolic picture looks like, the page on how semaglutide causes weight loss explains the mechanism clearly. And if you are also curious about other unexpected effects some people report, the pages on semaglutide and infections generally and on why Wegovy can be associated with urinary tract infections cover adjacent territory.

When this question comes up at a consultation

Our prescribers hear about yeast infections fairly regularly from people already on semaglutide, and occasionally from people worried about starting. It is one of those side effects that gets under-discussed in initial consultations because it feels embarrassing to raise. It should not. A good prescriber wants to know, because it can be a signal about how your glucose is responding to treatment.

If you are considering starting Wegovy and have a history of recurrent thrush or impaired glucose regulation, that context belongs in your consultation. It does not prevent treatment, but it shapes how your prescriber monitors you and what they advise alongside it. You can explore the treatment options and start a free consultation to have this conversation with a GPhC-registered Independent Prescriber who reviews your answers personally, the same day you submit them. If you want a broader overview of the treatment first, the Wegovy overview page covers eligibility, dosing context and what to expect.

These are prescription-only medicines. What suits you depends on your full medical history, not just a single symptom, and that is exactly what the consultation is for.